Roche and Affymetrix collaborate on cystic fibrosis testing
This article was originally published in Clinica
Executive Summary
Roche Molecular Systems and Affymetrix are to collaborate on the development of a cystic fibrosis mutation test. The two companies will attempt to combine Affymetrix' GeneChip with Roche's multiplex PCR to amplify and then detect mutations in the cystic fibrosis transmembrane regulator gene.